参考文献/References:
1 Mitsuhashi N,Hayakawa K,Hasegawa M,et al.Clinical FDG-PET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor.Anticancer Res,1998,18(4B):2827-2832.
2 Kao CH,Hsieh JF,Tsai SC,et al.Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma.Ann Otol Rhinol Laryngol,2000,109(12 Pt 1):1130-1134.
3 Yen TC,Chang JT,Ng SH,et al.The value of 18F-FDG PET in the detection of stage MO carcinoma of the nasopharynx.J Nucl Med,2005,46(3):405-410.
4 Kao CH,Shiau YC,Shen YY,et al.Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography:comparison with 18-fluoro-2-deoxyglucose positron emission tomography.Cancer,2002,94(7):1981-1986.
5 Kao CH,Tsai SC,Wang JJ,et al.Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium-99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.Cancer,2001,92(2):434-439.
6 Kao CH,ChangLai SP,Chieng PU,et al.Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography.J Clin Oncol,1998,16(11):3550-3555.
7 Tsai MH,Huang WS,Tsai JJ,et al.Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings.Antieancer Res,2003,23(4):3513-3516.
8 Tsai MH,Shiau YC,Kao CH,et al.Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy.J Cancer Res Clin Oncol,2002,128(5):279-282.
9 Yen RF,Hung RL,Pan MH,et al.18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging.Cancer,2003,98(2):283-287.
10 Ng SH,Joseph CT,Chan SC,et al.Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.J Nucl Med,2004,45(10):1669-1676.
11 Liu SH,Chang JT,Ng SH,et al.False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient.Br J Radiol,2004,77(915):257-260.
12 余党凡, 左传涛, 戴嘉中, 等. FDG-PET/CT在鼻咽癌放疗后随访中的初步应用研究.癌症,英文版,2004,23(11 Suppl):1538-1541.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[11]田月丽,兰晓莉,张永学.18F-FDG PET/CT在鼻咽癌综合治疗后患者随访及预后评估中的价值[J].国际放射医学核医学杂志,2013,37(6):359.[doi:10.3760/cma.j.issn.1673-4114.2013.06.009]
TIAN Yue-li,LAN Xiao-li,ZHANG Yong-xue.Prognostic value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients follow-up after comprehensive therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):359.[doi:10.3760/cma.j.issn.1673-4114.2013.06.009]
[12]王颖,冯彦林.18F-FDG PET-CT在鼻咽癌靶区勾画及推量照射研究中的价值[J].国际放射医学核医学杂志,2011,35(2):84.[doi:10.3760/cma.j.issn.1673-4114.2011.02.005]
WANG Ying,FENG Yan-lin.Value of 18F-FDG PET-CT in nasopharyngeal carcinoma target delineation and radiotherapy boost[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(2):84.[doi:10.3760/cma.j.issn.1673-4114.2011.02.005]
[13]冼伟均,冯彦林,袁建伟,等.18F-FDG PET-CT对裸鼠鼻咽癌移植瘤放疗疗效的早期评估及与Ki67表达的相关性研究[J].国际放射医学核医学杂志,2010,34(1):11.[doi:10.3760/cma.j.issn.1673-4114.2010.01.003]
XIAN Wei-jun,FENG Yan-lin,YUAN Jian-wei,et al.18F-FDG PET-CT in early assessing the therapeutic effects of nasopharyngeal carcinoma xenograft in nude mice after radiotherapy and it’s relativity to the expression of Ki67[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):11.[doi:10.3760/cma.j.issn.1673-4114.2010.01.003]
[14]吕清湖,唐明灯,林端瑜,等.原发鼻咽淋巴瘤与鼻咽癌的18F-FDG PET/CT诊断与鉴别[J].国际放射医学核医学杂志,2017,41(3):166.[doi:10.3760/cma.j.issn.1673-4114.2017.03.002]
Lyu Qinghu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT examination in the differential diagnosis of primary nasopharyngeal lymphoma and nasopharyngeal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(2):166.[doi:10.3760/cma.j.issn.1673-4114.2017.03.002]